MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Apellis Pharmaceuticals, Inc. Common Stock

APLS

#1497
Apellis Pharmaceuticals, Inc. Common Stock
20.96
-4.42%
Sector:
Base:
Profit Currency:
Daily Range
20.96
20.96
Year Range
16.10
30.48
Daily Change
-4.42%
Monthly Change
-6.05%
6 month change
-26.71%
Year Change
-19.38%
Previous Close
21.93
Open
20.96
Bid
Ask
Low
20.96
High
20.96
Volume
127
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. APLS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Zacks Zacks
APLS CSTL HRMY IMCR
2026.02.25
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
Investing Investing
APLS
2026.02.25
H.C. Wainwright raises Apellis stock price target on Syfovre outlook
Seeking Alpha Seeking Alpha
APLS
2026.02.24
Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript
Investing Investing
APLS
2026.02.24
Apellis Pharma earnings beat by $0.85, revenue topped estimates
Zacks Zacks
APLS FENC
2026.02.24
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates
Investing Investing
APLS
2026.02.24
Apellis Q4 2025 slides: dual product growth, path to profitability
Seeking Alpha Seeking Alpha
APLS
2026.02.24
Apellis Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:APLS) 2026-02-24
Investing Investing
APLS
2026.02.23
Apellis earnings on deck: Can new kidney drug revive growth momentum?
Zacks Zacks
KURA APLS
2026.02.18
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Zacks Zacks
APLS AXSM
2026.02.17
Earnings Preview: Apellis Pharmaceuticals, Inc. (APLS) Q4 Earnings Expected to Decline
Zacks Zacks
PCRX ZTS ACAD DNLI APLS
2026.02.03
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Zacks Zacks
APLS LXRX
2026.01.29
Apellis Pharmaceuticals (APLS) Surges 5.8%: Is This an Indication of Further Gains?

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd